We confirmed the generation of a higher number of MHC I‐Tetramer+ CD8+ T cells in LNs of rGL261‐MBTA vaccinated mice compared to age‐matched control mice (Figure 5C), indicating that rGL261‐MBTA vaccination established adaptive immunity against tumor‐specific antigens. The gene discussed is CD8A; the disease is neoplasm.